首页> Clinical infectious diseases : an official publication of the Infectious Diseases Society of America> Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein.

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein.

导出 OA

翻译打印收藏纠错

第一作者： Mina C,Hosseinipour

第一单位： University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.;UNC Project-Malawi, Lilongwe, Malawi.

作者： Mina C,Hosseinipour ^[1] ; Craig,Innes ^[2] ; Sarita,Naidoo ^[3] ; Philipp,Mann ^[4] ; Julia,Hutter ^[5] ; Gita,Ramjee ^[3] ; Modulakgotla,Sebe ^[6] ; Lucas,Maganga ^[7] ; Michael E,Herce ^[8] ; Allan C,deCamp ^[4] ; Kyle,Marshall ^[4] ; One,Dintwe ^[9] ; Erica,Andersen-Nissen ^[9] ; Georgia D,Tomaras ^[10] ; Nonhlanhla,Mkhize ^[11] ; Lynn,Morris ^[11] ; Ryan,Jensen ^[4] ; Maurine D,Miner ^[4] ; Giuseppe,Pantaleo ^[12] ; Song,Ding ^[13] ; Olivier,Van Der Meeren ^[14] ; Susan W,Barnett ^[15] ; M Juliana,McElrath ^[4] ; Lawrence,Corey ^[4] ; James G,Kublin ^[4] ; HVTN 111 Protocol Team

作者单位： University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.;UNC Project-Malawi, Lilongwe, Malawi. ^[1] Aurum Institute, Klerksdorp, South Africa. ^[2] HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa. ^[3] Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. ^[4] Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. ^[5] Aurum Institute, Tembisa, South Africa. ^[6] NIMR-Mbeya Medical Research Center, Mbeya, Tanzania. ^[7] Centre for Infectious Disease Research in Zambia, Lusaka, Zambia. ^[8] Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.;Cape Town HVTN Immunology Laboratory, Cape Town, South Africa. ^[9] Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, USA. ^[10] National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa. ^[11] Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland. ^[12] EuroVacc Foundation, Lausanne, Switzerland. ^[13] GSK Vaccines, Rixensart, Belgium. ^[14] GSK Vaccines, Cambridge, Massachusetts, USA. ^[15]

关键词 Biojector DNA prime/protein boost HIV vaccine subtype C